Regorafenib and Yttrium-90 Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma
Latest Information Update: 02 Apr 2025
At a glance
- Drugs Regorafenib (Primary) ; Yttrium-90
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 02 Apr 2025 New trial record